MIT Holding, Inc. (MITD) Infuses Itself into the S
Post# of 36
Posted On: 01/15/2015 7:24:45 PM
MIT Holding, Inc. (MITD) Infuses Itself into the Southern Ambulatory Care Market
Ambulatory care is big business throughout the United States. According to CDC reports, over 136 million visits to emergency rooms and other ambulatory care providers were recorded throughout 2011. Of these visits, over 55 million, or about 40 percent, were reportedly from the southern region of the country. It is in this area that MIT Holding, Inc. (OTCQB: MITD), through its wholly-owned subsidiary, Medical Infusion Technologies, Inc., has been carving a niche into the competitive medical market since 1990.
Medical Infusion Technologies is a trusted provider of outpatient care services servicing a 22-county region ranging from Savannah, GA to Okatie, SC. The company’s primary services include providing ambulatory infusion therapy to patients with conditions requiring ongoing care that doesn’t, necessarily, call for recurring visits to hospitals. The company’s primary care center in Savannah offers patients access to comfortable private infusion suites and a professional medical staff to answer questions and provide needed treatments in a less strenuous environment.
In cases where intravenous medication or nutrient delivery become a recurring part of a patient’s life, the company offers home infusion training and delivery to increase convenience for patients. In this scenario, the company sends a highly trained staff member to equip the patient with the necessary knowledge and medications needed for self-administration of required, recurring medical treatments. Common types of therapies currently available for home infusion include hydration, inotropic therapy, antibiotics, antivirals, antifungals, limited chemotherapy, Synagis® and total parenteral nutrition (TPN).
Other in-home care services offered by the company include a host of perinatal services designed to limit the stresses and complications that can be associated with late-term pregnancy. Care options including pre-term labor, hyperemesis management, diabetes monitoring, hypertension treatment and coagulation disorders are potentially vital treatment capabilities provided to expectant mothers in the comfort of their own homes by MIT Holding, Inc. The company’s large delivery area and knowledgeable staff help recovering patients get the treatment and equipment needed without the stresses commonly associated with hospitals and emergency rooms. With the constantly changing landscape of the healthcare industry, continued evolution and growth initiatives will serve to validate the company’s business model into the future.
For more information on MIT Holding, visit www.mitholdingsinc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Ambulatory care is big business throughout the United States. According to CDC reports, over 136 million visits to emergency rooms and other ambulatory care providers were recorded throughout 2011. Of these visits, over 55 million, or about 40 percent, were reportedly from the southern region of the country. It is in this area that MIT Holding, Inc. (OTCQB: MITD), through its wholly-owned subsidiary, Medical Infusion Technologies, Inc., has been carving a niche into the competitive medical market since 1990.
Medical Infusion Technologies is a trusted provider of outpatient care services servicing a 22-county region ranging from Savannah, GA to Okatie, SC. The company’s primary services include providing ambulatory infusion therapy to patients with conditions requiring ongoing care that doesn’t, necessarily, call for recurring visits to hospitals. The company’s primary care center in Savannah offers patients access to comfortable private infusion suites and a professional medical staff to answer questions and provide needed treatments in a less strenuous environment.
In cases where intravenous medication or nutrient delivery become a recurring part of a patient’s life, the company offers home infusion training and delivery to increase convenience for patients. In this scenario, the company sends a highly trained staff member to equip the patient with the necessary knowledge and medications needed for self-administration of required, recurring medical treatments. Common types of therapies currently available for home infusion include hydration, inotropic therapy, antibiotics, antivirals, antifungals, limited chemotherapy, Synagis® and total parenteral nutrition (TPN).
Other in-home care services offered by the company include a host of perinatal services designed to limit the stresses and complications that can be associated with late-term pregnancy. Care options including pre-term labor, hyperemesis management, diabetes monitoring, hypertension treatment and coagulation disorders are potentially vital treatment capabilities provided to expectant mothers in the comfort of their own homes by MIT Holding, Inc. The company’s large delivery area and knowledgeable staff help recovering patients get the treatment and equipment needed without the stresses commonly associated with hospitals and emergency rooms. With the constantly changing landscape of the healthcare industry, continued evolution and growth initiatives will serve to validate the company’s business model into the future.
For more information on MIT Holding, visit www.mitholdingsinc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)MIT Holding, Inc. (MITD) Stock Research Links
Scroll down for more posts ▼